AT365575B - Verfahren zur herstellung von neuen pyrrolidonen sowie deren physiologisch vertraeglichen metall- oder aminsalzen - Google Patents
Verfahren zur herstellung von neuen pyrrolidonen sowie deren physiologisch vertraeglichen metall- oder aminsalzenInfo
- Publication number
- AT365575B AT365575B AT0467976A AT467976A AT365575B AT 365575 B AT365575 B AT 365575B AT 0467976 A AT0467976 A AT 0467976A AT 467976 A AT467976 A AT 467976A AT 365575 B AT365575 B AT 365575B
- Authority
- AT
- Austria
- Prior art keywords
- pyrrolidones
- amine salts
- physiologically compatible
- producing new
- compatible metal
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000002184 metal Substances 0.000 title 1
- 150000004040 pyrrolidinones Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19752528664 DE2528664A1 (de) | 1975-06-27 | 1975-06-27 | Pyrrolidone und verfahren zu ihrer herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA467976A ATA467976A (de) | 1981-06-15 |
AT365575B true AT365575B (de) | 1982-01-25 |
Family
ID=5950059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0467976A AT365575B (de) | 1975-06-27 | 1976-06-25 | Verfahren zur herstellung von neuen pyrrolidonen sowie deren physiologisch vertraeglichen metall- oder aminsalzen |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS525764A (forum.php) |
AT (1) | AT365575B (forum.php) |
BE (1) | BE843505A (forum.php) |
CH (1) | CH623809A5 (forum.php) |
DE (1) | DE2528664A1 (forum.php) |
DK (1) | DK287476A (forum.php) |
ES (1) | ES449095A1 (forum.php) |
FR (1) | FR2316943A1 (forum.php) |
GB (1) | GB1553595A (forum.php) |
IL (1) | IL49916A0 (forum.php) |
LU (1) | LU75235A1 (forum.php) |
NL (1) | NL7606773A (forum.php) |
SE (1) | SE7607331L (forum.php) |
ZA (1) | ZA763802B (forum.php) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE423813B (sv) * | 1976-08-06 | 1982-06-07 | Pfizer | Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper |
US4772601A (en) * | 1988-01-25 | 1988-09-20 | Hoechst-Roussel Pharmaceuticals, Inc. | 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use |
AU1293101A (en) | 1999-12-22 | 2001-07-03 | Pfizer Products Inc. | Ep4 receptor selective agonists in the treatment of osteoporosis |
WO2002024647A1 (fr) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine |
EA200300379A1 (ru) | 2000-11-27 | 2003-08-28 | Пфайзер Продактс Инк. | Селективные агонисты рецептора ep4 в лечении остеопороза |
EP1408961B1 (en) | 2001-07-16 | 2007-07-11 | F. Hoffmann-La Roche Ag | 2 pyrrolidone derivatives as prostanoid agonists |
MXPA04000456A (es) | 2001-07-16 | 2004-03-18 | Hoffmann La Roche | Analogos de prostaglandina como agonistas del receptor ep4. |
TWI313608B (en) | 2001-07-23 | 2009-08-21 | Ono Pharmaceutical Co | Lower bone mass treating agent containing er4 agonist as active ingredient |
JP2005531516A (ja) * | 2002-03-18 | 2005-10-20 | ファイザー・プロダクツ・インク | 選択的ep4受容体アゴニストによる治療方法 |
US6573294B1 (en) * | 2002-05-14 | 2003-06-03 | Allergan, Inc. | 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
BRPI0406717A (pt) | 2003-01-10 | 2005-12-20 | Hoffmann La Roche | Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção |
US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
HUE031885T2 (en) | 2012-07-19 | 2017-08-28 | Cayman Chemical Co Inc | Difluoro lactam preparations for EP4-mediated osteo-related diseases and conditions |
WO2014144610A1 (en) * | 2013-03-15 | 2014-09-18 | Cayman Chemical Company, Inc. | Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions |
WO2014144500A2 (en) | 2013-03-15 | 2014-09-18 | Cayman Chemical Company, Inc. | Methods of synthesizing a difluorolactam analog |
EP3235817B1 (en) | 2013-03-15 | 2018-12-12 | Cayman Chemical Company, Incorporated | Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions |
CA2910398A1 (en) | 2013-07-19 | 2015-01-22 | Cayman Chemical Company, Inc. | Methods, systems, and compositions for promoting bone growth |
-
1975
- 1975-06-27 DE DE19752528664 patent/DE2528664A1/de not_active Withdrawn
-
1976
- 1976-06-22 ES ES449095A patent/ES449095A1/es not_active Expired
- 1976-06-22 NL NL7606773A patent/NL7606773A/xx not_active Application Discontinuation
- 1976-06-24 CH CH809976A patent/CH623809A5/de not_active IP Right Cessation
- 1976-06-24 SE SE7607331A patent/SE7607331L/xx unknown
- 1976-06-24 LU LU75235A patent/LU75235A1/xx unknown
- 1976-06-25 ZA ZA763802A patent/ZA763802B/xx unknown
- 1976-06-25 DK DK287476A patent/DK287476A/da unknown
- 1976-06-25 GB GB26564/76A patent/GB1553595A/en not_active Expired
- 1976-06-25 AT AT0467976A patent/AT365575B/de active
- 1976-06-25 IL IL49916A patent/IL49916A0/xx unknown
- 1976-06-26 JP JP51075954A patent/JPS525764A/ja active Pending
- 1976-06-28 FR FR7619563A patent/FR2316943A1/fr active Granted
- 1976-06-28 BE BE168390A patent/BE843505A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL49916A0 (en) | 1976-08-31 |
SE7607331L (sv) | 1976-12-28 |
DK287476A (da) | 1976-12-28 |
ATA467976A (de) | 1981-06-15 |
JPS525764A (en) | 1977-01-17 |
GB1553595A (en) | 1979-09-26 |
FR2316943B1 (forum.php) | 1978-11-03 |
DE2528664A1 (de) | 1977-01-13 |
FR2316943A1 (fr) | 1977-02-04 |
ZA763802B (en) | 1977-05-25 |
CH623809A5 (en) | 1981-06-30 |
ES449095A1 (es) | 1977-12-16 |
NL7606773A (nl) | 1976-12-29 |
LU75235A1 (forum.php) | 1977-03-16 |
BE843505A (fr) | 1976-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT340895B (de) | Verfahren zur herstellung von neuen p-trifluormethylacylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen | |
AT357534B (de) | Verfahren zur herstellung von neuen pyridinyl-2 (1h)-pyridinonen und deren saeureadditionssalzen | |
AT361937B (de) | Verfahren zur herstellung von neuen 4-acyl- aminophenyl-aethanolaminen und deren saeure- additionssalzen | |
AT365575B (de) | Verfahren zur herstellung von neuen pyrrolidonen sowie deren physiologisch vertraeglichen metall- oder aminsalzen | |
AT358555B (de) | Verfahren zur herstellung von neuen n-amino- alkyl-2-methoxy-benzolsulfonamiden sowie deren saeureadditionssalzen | |
AT359523B (de) | Verfahren zur herstellung von neuen 6-amino- alkylaminouracilen sowie deren saeureadditions- salzen | |
AT362366B (de) | Verfahren zur herstellung von neuen 5-methyl- -isoxazol-4-carbonsaeureamiden sowie deren salzen | |
AT347463B (de) | Verfahren zur herstellung von neuen 1,1,1- triarylalkylaminen und deren saeureadditions- salzen | |
AT346303B (de) | Verfahren zur herstellung von neuen 7- aminobenzocycloheptenen und deren saeure- additionssalzen | |
AT363923B (de) | Verfahren zur herstellung von neuen 8-amino-alkyltetracyclononanen und von deren saeureadditionssalzen | |
AT361904B (de) | Verfahren zur herstellung von neuen 3-anilino- aethylamino-2-hydroxy-1-phenoxypropanen sowie deren saeureadditionssalzen | |
AT359474B (de) | Verfahren zur herstellung von neuen 5-phenoxy- 6,7,8,9-tetrahydro-cyclohepten-7-aminen und von deren saeureadditionssalzen | |
AT340896B (de) | Verfahren zur herstellung von neuen p-halogen-acylophenon- o - (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
ATA606377A (de) | Verfahren zur herstellung von neuen 1-disubstiuierten phenoxy-2-hydroxy-3-diphenylmethylamino- und -3- (9'-fluorenylamino)-propanen sowie deren saureadditionssalzen | |
ATA328376A (de) | Verfahren zur herstellung von neuen 3-aminomethyl-2-phenylbicyclo(2,2,2)octanen und deren saureadditionssalzen | |
AT342565B (de) | Verfahren zur herstellung von neuen 3,4-dichlorphenon-o-(2-aminoathyl)-oximathern und deren saureadditionssalzen | |
AT360033B (de) | Verfahren zur herstellung von neuen tetrahydro- -s-triazinthionen und deren saeure- additionssalzen | |
AT340897B (de) | Verfahren zur herstellung von neuen p-methylthioacylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
AT360010B (de) | Verfahren zur herstellung von neuen azabicyclo- alkanen und deren physiologisch vertraeglichen saeureadditionssalzen | |
AT340894B (de) | Verfahren zur herstellung von neuen p-nitro-acylophenon-o- (2-aminoathyl) -oximather und deren saureadditionssalzen | |
AT369740B (de) | Verfahren zur herstellung von neuen thiodibenzthiepinen und deren saeureadditionssalzen | |
AT342021B (de) | Verfahren zur herstellung von neuen p-methylsulfinyl-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
AT348979B (de) | Verfahren zur herstellung von neuen 7-aminomethylbenzocycloheptenen und deren saeureadditonssalzen | |
ATA59280A (de) | Verfahren zur herstellung von neuen 3-anilinoaethylamino-2-hydroxy-1-phenoxypropanen sowie deren saeureadditionssalzen | |
ATA214677A (de) | Verfahren zur herstellung von neuen 7,7- -dimethyl-1-aminoalkyl-(2,2,1)-bicycloheptanen und von deren saeureadditionssalzen |